When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KRYS - Krystal Biotech initiates early-stage study of gene therapy for rare skin disorder
Krystal Biotech Inc.
Krystal Biotech (KRYS+2%) launches a Phase 1/2 clinical trial, GEM-3, evaluating gene therapy KR105 in patients with transglutaminase-1 (TGM1) deficient autosomal recessive congenital ichthyosis (ARCI), a rare inherited disorder characterized by thick scaling of the skin affecting ~23K people worldwide.
More news on: Krystal Biotech, Inc., Healthcare stocks news, Stocks on the move,